1. health and fitness
2. disease
3. cancer

AHPBA Sponsored Consensus Conference on the
Multidisciplinary
Treatment of
Bile Duct Cancer
Wednesday, January 15, 2014
San Francisco Marriott Marquis
55 Fourth Street
San Francisco, California
Multidisciplinary Treatment of Bile Duct Cancer (BDC)
Wednesday, January 15, 2014 San Francisco Marriott Marquis
55 Fourth Street • San Francisco, California
Goal
The focus of this consensus conference is the multidisciplinary management
of patients with bile duct cancers. The aim of this conference is to review the
current indications for surgical treatment, non-surgical interventions, and
adjuvant therapy for bile duct cancer. This topic has not previously been
discussed in a consensus conference format, and therefore, there is likely to
be a high education yield for participants. The format will divide the conference
into three sessions, individually focusing on Intrahepatic Cholangiocarcinoma,
Extrahepatic Cholangiocarcinoma, and Gallbladder Cancer. The program
features an expert multispecialty international group of speakers, panelists,
and moderators with
extensive experience
in the diagnosis, staging,
treatment, and research
related to the state-ofthe-art treatment of
patients with bile duct
malignancy. The goal of
this meeting is to provide
a forum to review,
discuss, and establish
current practice guidelines
and consensus statements.
At the conclusion of the
conference, attendees
should leave with a higher
level of understanding
and competence in the
diagnosis and
management of these
disorders.
*Not an official event of the
2014 Gastrointestinal Cancers
Symposium. Not sponsored
or endorsed by any of the
co-sponsoring organizations
of the 2014 Gastrointestinal
Cancers Symposium.
Educational Objectives
After attending the conference, participants should be able to
- Appropriately apply diagnostic and staging modalities to bile duct cancer patients (Knowledge,
Competence, Performance);
- Appropriately select the proper surgical treatment modalities available for the
management of bile duct cancer (Knowledge, Competence, Performance);
- Appropriately select and sequence the best multiple interventional and nonsurgical treatment
modalities available for optimal management of bile duct cancer (Knowledge, Competence,
Performance, Patient Outcomes);
- Appropriately implement the most up-to-date systemic cytotoxic and biologic strategies in the
management of bile duct cancer to improve patient outcomes (Knowledge, Competence,
Performance, Patient Outcomes).
Target Audience
This conference will be beneficial to surgical oncologists, medical oncologists, radiologists,
and interventional radiologists.
Educational Methods
Lectures – Question and Answer – Panel Discussions – Videos
Evaluation
A course evaluation form will provide participants with the opportunity to comment on the value of
the program content to their practice decisions, performance improvements activities, or possible
impact on patient health status. Participants will also have the opportunity to comment on any
perceived commercial bias in the presentations as well as to identify future educational topics.
Accreditation/Credit Designation
This activity has been planned and implemented in accordance with the Essential Areas and
Policies of the Accreditation Council for Continuing Medical Education through the joint
sponsorship of The University of Texas MD Anderson Cancer Center and The Americas
Hepato-Pancreato-Biliary Association. The University of Texas MD Anderson Cancer Center is
accredited by the ACCME to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum
of 7.50 AMA/PRA Category 1 Credits TM . Physicians should only claim the credit commensurate with
the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA/PRA Category 1 Credit TM or certificates documenting attendance
will be distributed to participants when an individual departs the conference. To obtain a
CME certificate, physicians must submit a completed evaluation questionnaire and a
CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site to other health care
professionals for requesting credits in accordance with state nursing boards, specialty societies,
or other professional associations.
Program Planning Committee
Program
Wednesday, January 15, 2014
Thomas A. Aloia, MD, Co-Chair
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Nipun B. Merchant, MD
Vanderbilt University
Medical Center
Nashville, Tennessee
John C. Mansour, MD, Co-Chair
The University of Texas
Southwestern Medical Center
Dallas, Texas
Carl R. Schmidt, MD
The Ohio State University
Columbus, Ohio
7:50–8:00
Introduction
William C. Chapman, MD
Sharon M. Weber, MD, Co-Chair
University of Wisconsin
Madison, Wisconsin
Jean-Nicolas Vauthey, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas
8:00–10:30
Eren Berber, MD
Cleveland Clinic
Cleveland, Ohio
Theodore H. Welling, III, MD
University of Michigan
Ann Arbor, Michigan
SESSION I: GALLBLADDER CANCER Moderators: Felipe José Fernández Coimbra, MD;
William R. Jarnagin, MD
Panelists: Rachna T. Shroff, MD; Elijah Dixon, MD;
Jennifer Knox, MD
William C. Chapman, MD
Washington University
School of Medicine
St. Louis, Missouri
Adam Yopp, MD
University of Texas
Southwestern Medical Center
Dallas, Texas
Alessandro Landskron Diniz, MD
AC Camargo Cancer Center
Sao Paulo, Brazil
George Zogopoulos, MD, PhD
McGill University
Montreal, Quebec
Canada
Cristina R. Ferrone, MD
Massachusetts General Hospital
Boston, Massachusetts
William Hawkins, MD
Washington University
School of Medicine
St. Louis, Missouri
Jill Kawulok
AHPBA
Leawood, Kansas
Nonie Lowry
AHPBA
Leawood, Kansas
William R. Jarnagin, MD
Memorial Sloan-Kettering
Cancer Center
New York, New York
Brigitte M. Taylor, CAP
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Byrne Lee, MD
City of Hope
Duarte, California
Constance C. Tierney, CMP
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Shishir K. Maithel, MD
Emory University
Atlanta, Georgia
7:00–7:50 a.m. Continental Breakfast/Registration
Pathologic Evaluation for Patients
With Gallbladder Polyps and Suspicion of
Early Stage Gallbladder Cancer
Juan Carlos Roa, MD, MSc
8:20–8:30
Discussion
8:30–8:50
Evaluation and Management
of the Patient Presenting With
a Gallbladder Mass
Nicolas Járufe Casis, MD
8:50–9:00
Discussion
9:00–9:20
Incidentally Discovered
Gallbladder Cancer:
The Gallbladder is Out,
Now What Do We Do?
Shishir K. Maithel, MD
9:20–9:30
Discussion
9:30–9:50
Advances in Neoadjuvant and
Adjuvant Chemotherapy and Radiation
Approaches to Gallbladder Cancer
Milind Javle, MD
9:50–10:00
Discussion
8:00–8:20
10:00-10:30Break
10:30a.m.–12:30 p.m. SESSION II: INTRAHEPATIC CHOLANGIOCARCINOMA (IHCCA)
Moderators: Masaru Miyazaki, MD; Sharon M. Weber, MD
Panelists: Ghassan K. Abou-Alfa, MD; Michael A. Choti, MD, MBA;
Michael I. D’Agelica, MD; Jeff Geschwind, MD
10:30–10:50
Recommendations for Diagnosis and Staging of IHCCA
Timothy M. Pawlik, MD, MPH, PhD
10:50–11:00Discussion
11:00–11:20
Local-Regional Treatment Strategies for IHCCA
Dario Ribero, MD
11:20–11:30Discussion
11:30–11:50
Hepatocholangiocarcinoma:
Defining and Treating An Emerging Entity
Norihiro Kokudo, MD, PhD
11:50–NoonDiscussion
Noon–12:20
Chemotherapy and Radiation Therapy for IHCCA
Eileen M. O’Reilly, MD
12:20–12:30 p.m.Discussion
12:30–1:30
Lunch at the Movies: Case Presentations With Video
Moderators: David M. Nagorney, MD; Paul D. Greig, MD
Invited Presenters: Thomas A. Aloia, MD; Julie K. Heimbach, MD;
William R. Jarnagin, MD; Nicolas Járufe Casis, MD;
Norihiro Kokudo, MD, PhD; Masaru Miyazaki, MD;
Masato Nagino, MD
1:30–3:30
SESSION III: HILAR CHOLANGIOCARCINOMA
Moderators: John C. Mansour, MD; Jean-Nicolas Vauthey, MD
Panelists: Alessandro Landskron Diniz, MD; Christopher E. Forsmark, MD
Andrew X. Zhu, MD, PhD
1:30–1:50
Multimodality Evaluation of Patients With Suspected
Hilar Cholangiocarcinoma: Including When to Proceed
Without a Tissue Diagnosis
Thomas A. Aloia, MD
1:50–2:00Discussion
2:00–2:20
Transplantation for Hilar Cholangiocarcinoma
With and Without PSC
Julie K. Heimbach, MD
2:20–2:30Discussion
2:30–2:50
Resectional Strategies for Hilar Cholangiocarcinoma Including
Vascular Resection and the Concept of ‘No-Touch’
Masato Nagino, MD
2:50–3:00 Discussion
3:00–3:20
Traditional and Novel Chemotherapy and Radiation
Approaches to Hilar Cholangiocarcinoma
Christopher Crane, MD
3:20–3:30Discussion
3:30–3:40 p.m Closing Comments
Sharon M. Weber, MD
Faculty
Registration Information
Ghassan K. Abou-Alfa, MD
Memorial Sloan-Kettering Cancer Center
Weill Medical College at Cornell University
New York, New York
Jennifer Knox, MD, MSc
University of Toronto
Princess Margaret
Toronto, Ontario, Canada
On-site registration opens at 7:00 a.m. on Wednesday, January 15, 2014 at the San Francisco Marriott
Marquis. The opening session of the conference will begin at 7:50 a.m. and the conference will adjourn
at 3:40 p.m. on Wednesday, January 15, 2014. Advance registration is encouraged as space and
materials are limited. Please see registration form for applicable fees.
Thomas A. Aloia, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Norihiro Kokudo, MD, PhD
University of Tokyo Graduate School of Medicine
Tokyo, Japan
The deadline for advance registration is January 6, 2014.
William C. Chapman, MD
Washington University School of Medicine
St. Louis, Missouri
Michael A. Choti, MD, MBA
University of Texas Southwestern
Dallas, Texas
Felipe José Fernández Coimbra, MD
AC Camargo Hospital
Sao Paulo, Brazil
Christopher Crane, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Michael I. D’Angelica, MD
Memorial Sloan-Kettering Cancer Hospital
New York, New York
Alessandro Landskron Diniz, MD
AC Camargo Cancer Center
Sao Paulo, Brazil
Elijah Dixon, MD
University of Calgary
Calgary, Alberta, Canada
Christopher E. Forsmark, MD
University of Florida
College of Medicine
Gainesville, Florida
Jeff Geschwind, MD
Johns Hopkins University
School of Medicine
Baltimore, Maryland
Paul D. Greig, MD
University of Toronto
Toronto, Ontario, Canada
Julie K. Heimbach, MD
Mayo Clinic
Rochester, Minnesota
William R. Jarnagin, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Nicolas Járufe Casis, MD
Pontificia Unversidad Catolica de Chile
Santiago, Chile
Milind Javle, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Shishir K. Maithel, MD
Emory University
Atlanta, Georgia
John C. Mansour, MD
University of Texas Southwestern Medical Center
Dallas, Texas
Masaru Miyazaki, MD
Chiba University Graduate School of Medicine
Chiba, Japan
Masato Nagino, MD, PhD
Nagoya University Graduate School of Medicine
Nagoya, Japan
David M. Nagorney, MD
Mayo Clinic College of Medicine
Rochester, Minnesota
Eileen M. O’Reilly, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Timothy M. Pawlik, MD, MPH, PhD
Johns Hopkins Hospital
Baltimore, Maryland
Dario Ribero, MD
Ospedale Ordine Mauriziano “Umberto I”
Torino, Italy
Juan Carlos Roa, MD, MSc
Pontificia Universidad Catolica de Chile
Santiago, Chile
Rachna T. Shroff, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Jean-Nicolas Vauthey, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Sharon M. Weber, MD
University of Wisconsin
Madison, Wisconsin
Andrew X. Zhu, MD, PhD
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
There are three ways to register:
• Mail to: CME/Conference Management – Unit 1381, The University of Texas
MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439
• Fax to: 713-794-1724
• On-line at www.mdanderson.org/conferences
We accept the following forms of payment:
• Check (payable through U.S. banks only)
• Money Order
• Credit Cards (MasterCard, VISA, and American Express)
• Cash (on-site registration)
A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee.
The full conference registration fee includes the tuition, abstract book, breaks, and lunch.
Refund/Cancellation Policy: The registration fee, minus a $50 administrative handling fee, is
refundable if a written request is received on or before January 6, 2014. No refunds will be granted
after that date. The request for a registration refund must include the tax identification number of the
company or institution if registration was paid by a company or institution check. For additional
information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.
The Department of CME/Conference Management reserves the right to cancel activities prior to the
scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be
notified either by mail, e-mail, or the contact numbers as given on the registration form. In case of
activity cancellation, liability of the Department of CME/Conference Management is limited to the
registration fee. CME/Conference Management will refund the full registration fee.
The Department of CME/Conference Management reserves the right to limit the number of participants
in a program and is not responsible for any expenses incurred by an individual whose registration is not
confirmed and for whom space is not available.
For additional information, contact CME/Conference Management at 713-792-2223 or 866-849-5866.
(must provide letter from Director)
1 Trainees...................................... $125.00
IDT Approver E-mail
1 Postmarked after 1/07/14........ $ 300.00
MD Anderson Employee ID No. (REQUIRED)
1 Postmarked by 1/07/14............. $ 260.00
Fund Type
Fund
IDT Approver Name (First/Last) please print
Authorized Signature REQUIRED for credit card or IDT
Fund Group*
Department
Business Unit
Credit Card Number
Credit Card Holder Name (First/Last)
Phone (with area code)
Emergency Contact
E-mail Address (please print)
MD Anderson Interdepartmental Transfer (IDT) No.: *Fund Group 90 will not be accepted
Expiration Date
Charge the following:
oVISA
oMasterCard
oAmerican Express
Credit Card Holder Billing Address & ZIP Code
Fax (with area code)
Cell Phone (with area code)
Daytime Phone (with area code)
City
Street
FULL CONFERENCE
REGISTRATION FEE
Department of CME/Conference Management – Unit 1381
The University of Texas MD Anderson Cancer Center
PO Box 301439, Houston, TX 77230-1439
or fax to 713-794-1724
Make check or money order payable to:
The University of Texas MD Anderson Cancer Center
oNo
oYes
Physician
State/Foreign Country/Zip or Mail Code
ADDRESS TO:
Institution
Please let us know what specific topics,
issues or questions you wish to see
addressed or emphasized
in this activity. Fax or e-mail CME/
Conference Management. All responses
will be forwarded to the Program Chair
for consideration.
Specialty
Photographing, audio taping and
videotaping are prohibited.
Department (include box no.)
Agendas are subject to change because
we are always striving to improve the
quality of your educational experience.
MD Anderson may substitute faculty with
comparable expertise on rare occasions
necessitated by illness, scheduling
conflicts, and so forth.
AHPBA Sponsored Consensus Conference on the
Multidisciplinary Treatment of Bile Duct Cancer - January 15, 2014
The University of Texas MD Anderson
Cancer Center has implemented a process
whereby everyone who is in a position to
control the content of an educational
activity must disclose all relevant financial
relationships with any commercial interest
that could potentially affect the
information presented. MD Anderson
also requires that all faculty disclose any
unlabeled use or investigational use
(not yet approved for any purpose) of
pharmaceutical and medical device
products. Specific disclosure will be
made to the participants prior to the
educational activity.
CONFERENCE REGISTRATION - 0638/110845
The hotel is approximately 14 miles from San Francisco International Airport and 20 miles from the
Oakland Airport. Taxis are available at the approximate price of $40 one way from SFO and $60 one
way from Oakland. Super Shuttle is also available. Please call 415-558-8500 or book on line at
www.supershuttle.com.
MI
Ground Transportation
First
If you are attending the 2014 Gastrointestinal Cancers Symposium, hotel rooms are available at the
San Francisco Marriott Marquis, 55 Fourth Street, San Francisco, California. Reserve a room
through the Symposium website at gicasym.org.
Last Name
Accommodations
Highest Degree
THIS IS NOT A SELF-MAILER
Contact the Department of CME/Conference Management at 713-792-2223 or 866-849-5866 if you
have any special dietary or ADA accommodation needs.
AHPBA Sponsored Consensus Conference on the
Multidisciplinary Treatment of Bile Duct Cancer
Special Assistance
Department of CME/Conference Management - Unit 1381
The University of Texas MD Anderson Cancer Center
# 176700/110845/0638
PO Box 301439
Houston, TX 77230-1439
Non-Profit Org.
U.S. Postage
PAID
Houston, TX
Permit No. 7052